Supporting people to get tested and be free of hep C
We are closer than ever to achieving our shared goal of eliminating hepatitis C (hep C). This milestone can only be reached through the strength of continued collaboration. Explore the Hep C elimination resources below, which have been created as part of Gilead's commitment to overcoming the challenges healthcare stakeholders face in achieving this elimination goal.
Resources
PROVIDER FORUM MATERIALS
Gilead Hepatitis C Drug Treatment Services Provider Forum –
Mission, Charter &
Actions- Drug
Treatment Service (DTS) Hepatitis C Micro Elimination Criteria (One pager)
- Drug Treatment Service (DTS) Hepatitis C Micro Elimination
Criteria (Full
criteria)
- 2025 Revised HCV DTS Provider Forum Drug and Alcohol Service Standards for HCV and BBVs
- INHSU Conference Poster – Development of DTS Hepatitis C Micro-Elimination Criteria for People in Structured Treatment
- INHSU Conference Poster – DTS Forum Development of Hepatitis C Virus and Other Blood Borne Viruses Standards of Care
The Hepatitis C Drug Service Provider Forum – Progress to Elimination
(44 minutes, 08 seconds)
Find out what the Gilead HCV Drug Treatment Services Provider Forum has developed to support HCV elimination in drug and alcohol services, what the priorities are for 2024 and how your organisation can get involved.
Speakers:
Matt Milner, Gilead Sciences
Marlon Freeman, Hepatitis C Coordinator
Updates from INHSU 2024
(42 minutes, 59 seconds)
The annual conference of the International Network on Health and Hepatitis in Substance Users is the primary conference for HCV elimination for the people and communities supported by drug and alcohol services and prison healthcare. Hear about the key themes of this year’s conference and learn more about the best practices presented from health care practitioners and peers with lived experience from around the world.
Speakers:
Irfan Chhipa, Gilead Sciences
Louise Hansford, Board Member, International Network on Health and Hepatitis in Substance Users
Marlon Freeman, National HCV Coordinator, VIA
COMMISSIONING & SERVICE STANDARDS
Elimination 2024+ - What’s next for England?
(46 minutes)
Meet the clinical and programme leads for NHS England’s HCV Elimination Programme and learn what NHSE is prioritising for 2024 to help England eliminate HCV by 2025.
Speakers:
William McCully, Gilead Sciences
Professor Ashley Brown, Clinical Lead, NHSE HCV Elimination Programme
Mark Gillyon-Powell, Deputy Director - HCV Elimination & Health Inequalities, NHS England, Specialised Commissioning
Commissioning for Elimination: Sustainable HCV Pathways
(42 minutes, 28 seconds)
Find out how drug and alcohol commissioners in two different local authorities work closely with their services to commission and review BBV activities to help deliver HCV elimination locally, in line with the Provider Forum developed micro-elimination criteria and BBV standards.
Speakers:
Adrian Coleman, Gilead Sciences
Claire Brighton, Drug and Alcohol Programme Manager, Ealing Council
Lee Harrington, Public Health Specialist - Substance Use, Health Improvement, Public Health & Wellbeing, Lancanshire County Council
Drug treatment services Hep C pathway workshop feedback
(14 minutes, 50 seconds)
Attendees at the Hep C Elimination workshop event present the outcomes of their collaborative discussions around real-life barriers and opportunities along the service user and provider pathway in the management of hep C.
Speakers:
Dr Prun Bujral, Medical Director, Change Grow Live (Hep C Elimination meeting
co-chair)
Timothy Lilley, Patient Access to Care team, Gilead Sciences Ltd
Dean Linzey, BBV Consultant
Danny Morris, Midlands & West Regional Manager – Community Services, The Hepatitis C Trust
Dr Rebecca John, National Hepatitis C Lead, Turning Point
Debbie Moores, National Hepatitis C Coordinator, Humankind
DISEASE AWARENESS & HARM REDUCTION
- Be Free Of Hep C – Call To Action Pledge Poster
- Be Free Of Hep C – Hep C Awareness Speech Bubble
- Be Free Of Hep C – Disease Awareness Poster
- Be Free Of Hep C – Campaign Kit
- Hep C, Ki? – Pocket Card
- Hep
C, Ki? – Leaflet
- Hep C, Ki? – Disease Awareness Poster
- Hep C, Ki? – Disease Awareness Poster (Bengali)
- Hep C, Ki? – Disease Awareness Poster (Punjabi)
- Hep C, Ki? – Disease Awareness Poster (Urdu)
- INHSU Conference Poster – Delivery of National Blood Borne Virus Training to Prison Healthcare Staff Via an Online Platform
Every test counts
(41 minutes, 05 seconds)
In this special edition webinar, learn more about European Testing Week and hear real life stories from people who have had their lives transformed by being tested and treated for hepatitis C. Learn what you can do to help people using your services be free of hep C.
Speakers:
Wendy Tivey, Gilead Sciences
James Rock, Pan London Peer Programme Manager, UCLH Find & Treat BBV Coordinator & Specialist Outreach, The Hepatitis C Trust
Michael Roberts, Hepatitis C Trust Peer, The Hepatitis C Trust
At the heart of everything we do: A patient’s story
(7 minutes, 32 seconds)
Louise, cured from hep C, talks about her journey from diagnosis to treatment and being part of initiatives that achieved micro elimination.
Speakers:
Louise Hansford, NHS Addiction Provider Alliance (APA) / MPFT
Hepatitis C Micro Elimination: Reinfection and harm reduction
(38 minutes, 46 seconds)
In this meeting, Mark Roberts and Louise Wilkins discuss the topic of reinfections and harm reduction.
Speakers:
Sanjita Panchal, Gilead Sciences Ltd
Mark Roberts, North East & Cumbria, Peer Support Lead
Louise Wilkins, Nottinghamshire Healthcare Foundation Trust
European Testing Week Special – Testing & Treating Hep C in NSP Settings
(42 minutes, 35 seconds)
In this edition of the Be Free of Hep C webinar series, Gilead brings together frontline voices from across the UK to spotlight the critical role of Needle and Syringe Programmes (NSPs) and how they are a vital touchpoint for testing and treating hepatitis C in underserved communities.
Speakers:
Irfan Chhipa, Gilead Sciences
Emma Lamond, Director of Integrated Treatment, We Are With You
Clive Williams, Peer Support Lead, The Hepatitis C Trust
Suzanne Murphy, Peer Program Manager, The Hepatitis C Trust
Jailyn Duncanson, Harm Reduction Recovery Coordinator, Gateshead Recovery Partnership
TESTING STRATEGIES
The Hepatitis C Drug Service Provider Forum – Progress to Elimination
(44 minutes, 08 seconds)
Find out what the Gilead HCV Drug Treatment Services Provider Forum has developed to support HCV elimination in drug and alcohol services, what the priorities are for 2024 and how your organisation can get involved.
Speakers:
Matt Milner, Gilead Sciences
Marlon Freeman, Hepatitis C Coordinator
Sustaining Microelimination
(41 minutes, 01 seconds)
Learn how two different drug and alcohol services have sustained HCV micro-elimination for more than a year. Find out how they work in partnership with their local hepatology clinicians to support people using their services to Be Free of Hep C.
Speakers:
Christine Taylor, Gilead Sciences
Jael Mulholland, Hepatology Clinical Nurse Specialist, Chelsea and Westminster Hospital NHS Foundation Trust
Darja Golob, Addictions Performance Analyst, Central & North West London NHS Foundation Trust
Daniel Page, Deputy Service Manager, Waltham Forest, CGL
Jane Dalton, Community Viral Hepatitis Nurse Specialist, Royal London Hospital NHS Foundation Trust
Overcoming Refusals: Testing and Treatment Strategies
(32 minutes, 34 seconds)
Chaired by Tim Lilley, this webinar focuses on overcoming refusals and implementing effective Hepatitis C testing and treatment strategies. Featuring experts from CGL, including Jonathan Occleshaw, Alison Starkie, and Rachel Hudson, the session explores practical approaches to engaging clients in testing, ensuring successful treatment, and achieving micro-elimination across services in Lancashire and Hull.
Speakers:
Tim Lilley, Gilead Sciences
Johnathan Occleshaw, Hep C Regional Coordinator, Northwest, CGL
Alison Starkie, Hep C Intervention Worker, CGL
Rachel Hudson, Cluster Lead Nurse and Hepatitis C Treatment
Coordinator, Hull, Renew, CGL
Change Grow Live (CGL) Reading
(3 minutes, 43 seconds)
A motivational video from a Drug Treatment Services site, which achieved micro elimination of hep C; Safina Shahin, a Senior Healthcare Assistant, talks about how this was accomplished, and shares some of her best practice tips.
Change Grow Live (CGL) West Kent
(4 minutes, 35 seconds)
An inspirational video from a Drug Treatment Services site, which achieved micro elimination of hep C. Three members of the team responsible for this achievement; Jo Brown (Cluster Lead Nurse), Tracy Tinley (Substance Misuse RGN) and Linda Foreman (Viral Hepatitis CNS) talk about how they accomplished this.
Testing Events: Targeted strategies to support Micro Elimination
(41 minutes, 44 seconds)
Hepatitis C Trust representatives share how they are collaborating with DTSs to increase testing, and how these tactics supported Havering in becoming the first service to achieve hep C elimination in 2023.
Speakers:
Alan Howard, Peer-to-Peer Coordinator, Hepatitis C Trust Hampshire
Sean Caddy, Wessex Clinical Van Coordinator, Inclusion Recovery – Hampshire and Dorset
Isaac Onita, Blood Borne Virus (BBV) Lead, Aspire – Havering
Simon Pooley, Peer Project Manager, Hepatitis C Trust – North East London
Wendy Tivey, Gilead Sciences Ltd
Overcoming the challenges of achieving Micro Elimination in a large integrated service
(31 minutes)
Deborah Moores and Stacey Smith discuss the challenges of achieving micro-elimination in a large integrated service and how they overcome them.
Speakers:
Deborah Moores, National Hepatitis C Coordinator, Humankind
Stacey Smith, Director of Nursing, Humankind
Drug treatment services panel discussion – Ask the expert
(20 minutes, 29 seconds)
A multi-disciplinary panel explore and discuss topics around hep C treatment services, including engagement of local politicians, sharing of data between services, the impact of COVID-19 on service users and optimisation of access to services in the future. Facilitated by Rachel Halford, CEO, The Hepatitis C Trust
Speakers:
Rachel Halford, CEO, The Hepatitis C Trust
Dean Linzey, BBV Consultant
Professor John Dillon, Professor of Hepatology and Gastroenterology, Ninewells Hospital,
University of Dundee
Mark Gillyon-Powell, Head of Programme for Hep C Elimination in England, NHSE
Denise Burridge, Director of Nursing, Change Grow Live
Louise Hansford, Hep C Coordinator South, NHS APA (Inclusion) / MPFT
Stuart Smith, Director of Community Services, The Hepatitis C Trust
European Testing Week Special – Testing & Treating Hep C in NSP Settings
(42 minutes, 35 seconds)
In this edition of the Be Free of Hep C webinar series, Gilead brings together frontline voices from across the UK to spotlight the critical role of Needle and Syringe Programmes (NSPs) and how they are a vital touchpoint for testing and treating hepatitis C in underserved communities.
Speakers:
Irfan Chhipa, Gilead Sciences
Emma Lamond, Director of Integrated Treatment, We Are With You
Clive Williams, Peer Support Lead, The Hepatitis C Trust
Suzanne Murphy, Peer Program Manager, The Hepatitis C Trust
Jailyn Duncanson, Harm Reduction Recovery Coordinator, Gateshead Recovery Partnership
LINKAGE TO CARE
Drug treatment services panel discussion – Ask the expert
(20 minutes, 29 seconds)
A multi-disciplinary panel explore and discuss topics around hep C treatment services, including engagement of local politicians, sharing of data between services, the impact of COVID-19 on service users and optimisation of access to services in the future. Facilitated by Rachel Halford, CEO, The Hepatitis C Trust.
Speakers:
Rachel Halford, CEO, The Hepatitis C Trust
Dean Linzey, BBV Consultant
Professor John Dillon, Professor of Hepatology and Gastroenterology, Ninewells Hospital,
University of Dundee
Mark Gillyon-Powell, Head of Programme for Hep C Elimination in England, NHSE
Denise Burridge, Director of Nursing, Change Grow Live
Louise Hansford, Hep C Coordinator South, NHS APA (Inclusion) / MPFT
Stuart Smith, Director of Community Services, The Hepatitis C Trust
Assessing and Treating HCV: A Clinical Guide for DTS-Led Delivery
(51 minutes, 36 seconds)
The ninth Be Free of Hep C webinar focused on Assessing and Treating HCV: A Clinical Guide for DTS-Led Delivery, highlighting the evolution of treatment pathways in West Kent CGL. Speakers Jo Brown and Laura Gallagher discussed the shift from hospital-led care to in-service treatment, emphasising the importance of stakeholder collaboration, streamlined pathways, and empowering drug treatment services to deliver hepatitis C treatment directly, ensuring more accessible and patient-centred care.
Speakers:
Speakers:
Pinda Garcha, Gilead Sciences
Jo Brown, Change Grow Live
Laura Gallagher, South Thames ODN
Patient Group Directions (PGDs) and where they fit in Eliminating Hepatitis C
(45 minutes, 48 seconds)
Hear from experts discussing the evolving role of Patient Group Directions (PGDs) in hepatitis C care. This session highlighted how PGDs are enabling faster, more flexible treatment delivery in community settings, including mobile outreach and drug treatment services, helping to close the gap on elimination targets.
Speakers:
Pinda Garcha, Gilead Sciences
Kieran Reynolds, Specialist Pharmacist, Medicines Use and Safety team, NHS Specialist Pharmacy Service
Rhys Oakley, Consultant Pharmacist, Cardiff and Vale, University Health Board
Mark Cassell, Consultant Nurse in Viral Hepatitis, Sheffield Teaching Hospital NHS Foundation Trust
ENGAGEMENT & OUTREACH
Community Pharmacy Based Testing for HCV
(39 minutes, 07 seconds)
Community pharmacy can offer many opportunities to provide outreach services and support for people who may also access drug and alcohol services, including testing for hepatitis C. Learn about best practices being used by the Wessex Operational Delivery Network and the Hepatitis C Trust.
Speakers:
Pinda Garcha, Gilead Sciences
Dr Charlotte Cook, University of Southampton
Leila Reid, Director of Research and Corporate Services, The Hepatitis C Trust
HCV Testing and Needle & Syringe Provision
(40 minutes, 24 seconds)
As more drug and alcohol services reach HCV micro-elimination in structured care, needle and syringe provision services can offer new opportunities to engage people in testing and treatment for Hepatitis C. Hear about policy changes and pilot programmes that seek to increase testing in these settings.
Speakers:
Jenny Scott, PhD, Cert. IP, FRPharmS, FHEA. Senior Lecturer (Pharmacist) – Centre for Academic Primary Care (CAPC), Population Health Sciences, Bristol Medical School
Stuart Smith, Director of Community Services, The Hepatitis C Trust
BEYOND ENGLAND
Taking healthcare to patients
(10 minutes, 27 seconds)
Watch our inspiring webinar, Taking Healthcare to Patients, where we explore innovative approaches to delivering Hepatitis C testing, treatment, and care to those who need it most. Through personal stories from peers, volunteers, and patients, discover how community-led initiatives like Glasgow’s Bluevale Community Centre are making a tangible difference in eliminating Hepatitis C and overcoming barriers to care.
Speakers:
Speakers include the following employees, volunteers and attendees from BlueVale and the Hep C Trust:
Kenny, Jim, Laurence, Kevin, Colin and Colin